NEW YORK (GenomeWeb) – A new international consortium called SYSCID (A systems medicine approach to chronic inflammatory disease) has received €14.4 million ($15.3 million) to support a five-year research project with the goal of developing personalized medicine approaches for inflammatory bowel disease, rheumatoid arthritis, and systemic lupus erythematosus.

Coordinated by Kiel University in Germany, the effort involves academic and industry partners from nine different countries.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.